Comparative Study of Lidocaine and Ketamine Infusion for Postoperative Pain in Thyroidectomy Patients
This study compares the use of lidocaine and ketamine infusions to manage postoperative pain in thyroidectomy patients, evaluating their effect on pain reduction.
group L : will receive lidocaine
+ group k : will receive Ketamine
+ group c: will recieve .9% saline
Endocrine System Diseases
+ Thyroid Diseases
Other Study
Summary
Study start date: June 11, 2025
Actual date on which the first participant was enrolled.This clinical trial investigates how two different medications, lidocaine and ketamine, might help reduce pain after thyroid surgery, known as a thyroidectomy. The goal is to determine which medication is more effective at providing pain relief after the surgery. Patients undergoing thyroidectomy often experience postoperative pain, and finding the most effective way to manage this pain can improve recovery and comfort. Lidocaine and ketamine are both known for their pain-relieving properties, and this study seeks to identify which one offers better relief for patients. Participants in the study receive either lidocaine or ketamine through an intravenous (IV) drip during their surgery. This means the medication is delivered directly into the bloodstream through a vein. The study then monitors the level of pain relief each patient experiences after their surgery to evaluate the effectiveness of each drug. By comparing the pain levels reported by patients, the study aims to determine which drug provides better postoperative pain control. There are no specific outcomes listed, but the general focus is on the quality of pain relief provided by each medication.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.60 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Other Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 75 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.3 intervention groups are designated in this study
33.333% chance of being blinded to the placebo group
Treatment Groups
Group I
Active ComparatorGroup II
Active ComparatorGroup III
PlaceboStudy Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location